Hims & Hers Health (NYSE:HIMS) Downgraded by Morgan Stanley to Equal Weight
Morgan Stanley cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from an overweight rating to an equal weight rating ...
Piper Sandler Sticks to Its Sell Rating for Albemarle (ALB)
Piper Sandler analyst Charles Neivert maintained a Sell rating on Albemarle (ALB – Research Report) today and set a price target of $85.00. The ...
Piper Sandler cuts McDonald's stock price target to $290
Piper Sandler adjusted its outlook on McDonald's Corporation (NYSE:MCD) shares, reducing the price target from the previous $297.00 to $290.00 while maintaining a Neutral rating on the stock.
Piper Sandler Reaffirms “Neutral” Rating for Biogen (NASDAQ:BIIB)
Biogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “neutral” rating reiterated by equities research analysts at Piper ...
Hosted on MSN15d
Piper Sandler raises Nevro stock to Neutral, cuts target to $5.85
On Friday, Piper ... market. Morgan Stanley (NYSE:MS), however, downgraded Nevro's stock from Equalweight to Underweight and reduced its price target due to challenges faced by the company ...
Molson Coors (TAP) Receives a Hold from Morgan Stanley
Morgan Stanley analyst Eric Serotta maintained a Hold rating on Molson Coors (TAP – Research Report) today and set a price target of $63.00.